Edition:
United Kingdom

Prophase Labs Inc (PRPH.OQ)

PRPH.OQ on NASDAQ Stock Exchange Capital Market

2.94USD
23 Apr 2018
Change (% chg)

$-0.03 (-1.01%)
Prev Close
$2.97
Open
$2.94
Day's High
$2.94
Day's Low
$2.94
Volume
213
Avg. Vol
2,456
52-wk High
$3.43
52-wk Low
$1.85

Chart for

About

ProPhase Labs, Inc. manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company's products include TK... (more)
No analyst recommendations are available for .

Overall

Beta: 0.03
Market Cap(Mil.): $36.91
Shares Outstanding(Mil.): 12.43
Dividend: --
Yield (%): --

Financials

  PRPH.OQ Industry Sector
P/E (TTM): 3.13 20.66 41.39
EPS (TTM): 0.92 -- --
ROI: 81.63 11.47 60.68
ROE: 81.63 15.09 73.62

BRIEF-Prophase Labs Announces New Compensatory Arrangement With CEO And Termination Of Stockholder Rights Plan

* PROPHASE LABS, INC. ANNOUNCES NEW COMPENSATORY ARRANGEMENT WITH CHIEF EXECUTIVE OFFICER AND TERMINATION OF STOCKHOLDER RIGHTS PLAN

21 Feb 2018

BRIEF-ProPhase Labs quarterly loss per share $0.05 from continuing operations

* ProPhase Labs reports financial results for the three months and nine months ended September 30, 2017

13 Nov 2017

BRIEF-Prophase Labs intends to commence tender offer to repurchase up to 1.7 mln shares

* Prophase Labs, Inc. announces intention to commence tender offer to repurchase up to 1,700,000 shares of its common stock

10 Nov 2017

Earnings vs. Estimates

No consensus analysis data available.